APA

van der Velden D., Lagraauw H. M., Wezel A., Launay P., Kuiper J., Huizinga T. W. J., Toes R. E. M., Bot I. & Stoop J. N. (20171107). Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. : Arthritis research & therapy.

Chicago

van der Velden Daniël, Lagraauw H Maxime, Wezel Anouk, Launay Pierre, Kuiper Johan, Huizinga Tom W J, Toes René E M, Bot Ilze and Stoop Jeroen N. 20171107. Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. : Arthritis research & therapy.

Harvard

van der Velden D., Lagraauw H. M., Wezel A., Launay P., Kuiper J., Huizinga T. W. J., Toes R. E. M., Bot I. and Stoop J. N. (20171107). Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. : Arthritis research & therapy.

MLA

van der Velden Daniël, Lagraauw H Maxime, Wezel Anouk, Launay Pierre, Kuiper Johan, Huizinga Tom W J, Toes René E M, Bot Ilze and Stoop Jeroen N. Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile. : Arthritis research & therapy. 20171107.